These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35174591)

  • 21. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.
    Dini V; Barbanera S; Romanelli M
    Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925
    [No Abstract]   [Full Text] [Related]  

  • 23. Acrodermatitis continua of Hallopeau: historical perspectives and modern management.
    Bhate C; Schwartz RA
    Ital J Dermatol Venerol; 2022 Apr; 157(2):132-136. PubMed ID: 35391533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
    Pearson LH; Allen BS; Smith JG
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous cell carcinoma mimicking acrodermatitis continua suppurativa in a patient with generalized pustular psoriasis.
    Balestri R; Magnano M; Ioris T; Girardelli CR; Rech G
    J Dtsch Dermatol Ges; 2023 May; 21(5):537-539. PubMed ID: 36960854
    [No Abstract]   [Full Text] [Related]  

  • 26. Acrodermatitis continua of Hallopeau with insufficient response to ixekizumab and infliximab, successfully treated with a combination of ustekinumab and tofacitinib.
    Chen X; Huang X; Ma L; Wang B; Tian J; Liu X
    Eur J Dermatol; 2023 Apr; 33(2):182-183. PubMed ID: 37431132
    [No Abstract]   [Full Text] [Related]  

  • 27. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis?
    Sahin MT; Oztürkcan S; Türel A; Kandiloğlu AR
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):236-8. PubMed ID: 12705767
    [No Abstract]   [Full Text] [Related]  

  • 28. Ixekizumab rapidly improves inflammatory markers in patients with generalized pustular psoriasis.
    Ito M; Kamata M; Uchida H; Egawa S; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Tada Y
    Br J Dermatol; 2022 Nov; 187(5):793-795. PubMed ID: 35661135
    [No Abstract]   [Full Text] [Related]  

  • 29. Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.
    Iijima S; Okazaki Y; Watanabe S; Maruyama Y
    J Dermatol; 2014 Nov; 41(11):1006-8. PubMed ID: 25346303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous cell carcinoma arising on acrodermatitis continua of Hallopeau: clinical and noninvasive skin imaging features.
    Cinotti E; Santi F; Perrot JL; Habougit C; Tognetti L; Rubegni P
    Int J Dermatol; 2021 Jun; 60(6):763-765. PubMed ID: 33241565
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acrodermatitis continua, pustular psoriasis and impetigo herpetiformis].
    VAN SCHOUWEN M
    Ned Tijdschr Geneeskd; 1953 Jan; 97(2):79-85. PubMed ID: 13054802
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of secukinumab-resistant palmoplantar pustulosis by Dupilumab: A case report.
    Zheng YX; Zheng M; Cai SQ
    Dermatol Ther; 2022 Nov; 35(11):e15781. PubMed ID: 35986706
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report.
    Passante M; Dastoli S; Nisticò SP; Bennardo L; Patruno C
    Dermatol Ther; 2020 Jan; 33(1):e13170. PubMed ID: 31762153
    [No Abstract]   [Full Text] [Related]  

  • 36. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
    Cirone KD; Lovegrove FE
    SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ixekizumab for acrodermatitis continua.
    Pilz AC; Roenneberg S; Biedermann T; Eyerich K
    J Dtsch Dermatol Ges; 2018 Jul; 16(7):907-910. PubMed ID: 29927543
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].
    García C; Arellano J; Vera V; Corredoira Y
    Medwave; 2020 Sep; 20(8):e8021. PubMed ID: 32956338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
    Lutz V; Lipsker D
    Arch Dermatol; 2012 Mar; 148(3):297-9. PubMed ID: 22431771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.